Skip to main content
. Author manuscript; available in PMC: 2017 Nov 15.
Published in final edited form as: Cancer. 2016 Jul 12;122(21):3316–3326. doi: 10.1002/cncr.30180

TABLE 3.

Severe Transplantation-Related Toxic Effects (From the Start of Conditioning Through Day 180)

Toxic Effect No. of Events (%)
HAPLO Arm, n = 60
9/10 MUD Arm, n = 46
Grade III Grade IV Grade III Grade IV
Bacterial infection 37 (62)   5 (8) 26 (57)   5 (11)
Viral infection 18 (30)   2 (3)   9 (20)   1 (2)
Fungal infection   2 (3)   2 (3)   3 (7)   0 (0)
Neutropenic fever 29 (48)   0 (0) 13 (28)   0 (0)
Hepatic effecta   6 (10)   0 (0)   3 (7)   3 (7)
Pulmonary effecta   4 (7)   0 (0)   1 (2)   1 (2)
Diffuse alveolar hemorrhage   1 (2)   0 (0)   0 (0)   0 (0)
Renal impairment   2 (3)   1 (2)   5 (11)   0 (0)
Mucositis   3 (5)   0 (0)   2 (4)   0 (0)
Nausea   2 (3)   0 (0)   1 (2)   0 (0)
Diarrhea   3 (5)   1 (2)   9 (20)   0 (0)
Skin rash   1 (2)   0 (0)   1 (2)   0 (0)
Neurologic effecta   0 (0)   1 (2)   0 (0)   0 (0)
Headache   0 (0)   0 (0)   0 (0)   1 (2)
Encephalopathy   0 (0)   0 (0)   0 (0)   1 (2)
Thrombotic microangiopathy   0 (0)   0 (0)   1 (2)   0 (0)
Veno-occlusive disease   0 (0)   0 (0)   1 (2)   1 (2)
Cardiac dysfunction   0 (0)   0 (0)   1 (2)   1 (2)

Abbreviations: 9/10 MUD, HLA-mismatched unrelated donor; HAPLO, haploidentical donor.

a

“Hepatic effect” indicates elevation of liver enzymes; “pulmonary effect” indicates hypoxia and/or dyspnea; and “neurologic effect” indicates cerebellar toxicity.

HHS Vulnerability Disclosure